Questions for a facility scope conversation.
What exists today, what the demonstration can show, and what must be in place before a future real-record pilot.
Can SMEG handle patient records today?
No. Real-record pilots are not yet available. Demonstrations use SMEG-supplied synthetic information only. Any future record review requires written facility authorization and completed BAA, vendor, security, access, intake, storage, retention, deletion, and qualified-reviewer approvals. A BAA alone is insufficient.
Do you replace my EHR?
No. The official chart stays in the facility-approved EHR and remains the source of truth. SMEG is designed to organize documentation concerns for review, not to write or approve the medical record.
What can a multi-building operator evaluate now?
A scope call and synthetic demonstration. Define the buildings, skilled-bed bands, PT/OT/SLP disciplines, payer contexts, sample size, reviewer responsibilities, and intended report. Cross-building reporting is a proposed scope item, not evidence of an established deployment.
Which guidance informs the review?
The proposed review separates Medicare Part A SNF coverage and PDPM payment-classification context from Part B outpatient therapy documentation and billing context. Payer, setting, discipline, note type, and missing context must be considered before a check is applied. Coaching prompts are not universal payer requirements.
Who makes the final review decision?
Qualified, discipline-appropriate human reviewers confirm, modify, dismiss, or escalate proposed findings; QA controls release. Reviewer qualifications and capacity must be agreed before a future pilot. SMEG does not replace facility clinical, compliance, billing, legal, MDS, or payer-policy authority.
Are EHR integrations live?
No live direct EHR integrations are offered. Any future export or integration workflow requires vendor approval, authorization, technical scoping, and security review. Do not send sample patient files to start a conversation.
Is there clinical validation or customer-outcome evidence?
Not yet. There is no completed clinical validation or customer-outcome evidence. Synthetic demos and passing software tests demonstrate neither clinical accuracy nor improved payer outcomes. The public examples are editorial demonstrations, not measured engine results.
Can one note establish MDS or PDPM accuracy?
No. A note excerpt does not establish the accuracy of a complete MDS assessment or payment classification. Applicable assessment, episode, and payer context would require authorized MDS and clinical review. PDPM is a Medicare Part A SNF payment-classification model, not a Part B checklist.
What could follow a synthetic demonstration?
If fit is established, a proposed founding pilot could be limited to 1–2 buildings, with written scope, agreed qualified reviewers and QA, and all readiness gates completed first. It is not available for real records today. Delivery timing and pricing require written agreement.
How is facility pricing scoped?
By facility size, skilled beds, number of buildings, PT/OT/SLP disciplines, proposed review volume, cadence, and support needs. No public fixed price, turnaround promise, or service commitment is created by the scope form.
Is a long-term contract required for a conversation?
No contract is required to discuss scope or view public synthetic examples. Any future engagement requires separately agreed terms. Monthly services, annual terms, and broader rollout are proposals, not available service packages.
How should we compare SMEG with our current QA?
Use the synthetic demo to examine evidence visibility, benefit-specific context, unavailable checks, reviewer decisions, and follow-up ownership. Compare those proposed outputs with your existing process; SMEG has not established superiority over another product or your internal team.
Still have questions?
Discuss your review workflow using organization-level information only; no patient records are needed.
Request Facility Pricing